Melanocortin-1 receptor variants and telomerase reverse transcriptase promoter mutations as prognostic biomarkers in stage IIB–IIC melanoma
Year: 2026
Type: article
Study design: Observational Study
Source: Melanoma Research
Institutions: Federico II University Hospital, University of Naples Federico II, Fundación Instituto Valenciano de Oncología, University of Salerno, German Cancer Research Center, Czech Academy of Sciences, Heidelberg University, Czech Academy of Sciences, Institute of Experimental Medicine, Valencia Catholic University Saint Vincent Martyr
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7164922831
